Skip to content
Ancell Corporation
Search
  • Shopping Cart
  • Contact Us / US Orders
  • International Orders
  • Terms
Ancell Corporation
Search
  • Home
  • Shopping Cart
  • Contact Us /US Orders
  • International Orders
  • Terms
  • Procedures
  • Material Safety Data Sheet (MSDS)
  • Hot Topics
  • Home
  • Products
    • New Products
    • Anti-Human Antibodies
    • Anti-Mouse Antibody
    • Cytokine related
    • Immune Checkpoint
    • Isotype Controls
    • Progenitor/Stem Cell
    • Recombinant Proteins
    • Second-Step Reagents
    • TNF Superfamily
  • Information
    • Hot Topics
    • US Orders / Price lists
    • International Orders
    • Procedures
    • MSDS

IL-6 inhibitor, Tocilizumab found to be effective in reducing severe Covid-19 symptoms

By room34 / January 6, 2021

A 195-participant-study found that this drug prolonged survival and lessened inflammation in patients with severe Covid-19.

“Repurposed Tocilizumab in Patients with Severe COVID-19” Jianbo Tian, Huilan Zhang , et al. (Dec 9, 2020) J Immunol ji2000981. doi: 10.4049/jimmunol.2000981.

← Previous Post
Next Post →

All prices are in U.S. dollars. International prices may vary.

Copyright © 2025 Ancell Corporation. All rights reserved.